Chronic low-dose isotretinoin treatment limits renal damage in subtotally nephrectomized rats.
Morath, Christian
Chronic low-dose isotretinoin treatment limits renal damage in subtotally nephrectomized rats. [electronic resource] - Journal of molecular medicine (Berlin, Germany) Jan 2009 - 53-64 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0946-2716
10.1007/s00109-008-0404-5 doi
Albuminuria--drug therapy
Animals
Anti-Inflammatory Agents, Non-Steroidal--pharmacology
Blood Pressure--drug effects
Cells, Cultured
Chronic Disease
Collagen Type V--biosynthesis
Dermatologic Agents--pharmacology
Dose-Response Relationship, Drug
Gene Expression Regulation--drug effects
Isotretinoin--pharmacology
Kidney Diseases--drug therapy
Male
Muscle, Smooth, Vascular--metabolism
Myocytes, Smooth Muscle--metabolism
Nephrectomy
Rats
Rats, Sprague-Dawley
Time Factors
Transforming Growth Factor beta1--biosynthesis
Chronic low-dose isotretinoin treatment limits renal damage in subtotally nephrectomized rats. [electronic resource] - Journal of molecular medicine (Berlin, Germany) Jan 2009 - 53-64 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0946-2716
10.1007/s00109-008-0404-5 doi
Albuminuria--drug therapy
Animals
Anti-Inflammatory Agents, Non-Steroidal--pharmacology
Blood Pressure--drug effects
Cells, Cultured
Chronic Disease
Collagen Type V--biosynthesis
Dermatologic Agents--pharmacology
Dose-Response Relationship, Drug
Gene Expression Regulation--drug effects
Isotretinoin--pharmacology
Kidney Diseases--drug therapy
Male
Muscle, Smooth, Vascular--metabolism
Myocytes, Smooth Muscle--metabolism
Nephrectomy
Rats
Rats, Sprague-Dawley
Time Factors
Transforming Growth Factor beta1--biosynthesis